Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Total Liabilities
Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has total liabilities worth CN¥162.39 Million CNY (≈ $23.76 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guangdong Jiaying Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Guangdong Jiaying Pharmaceutical Co Ltd - Total Liabilities Trend (2004–2025)
This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Guangdong Jiaying Pharmaceutical Co Ltd (002198) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bioteque
TWO:4107
|
Taiwan | NT$1.05 Billion |
|
Skel fjárfestingafélag hf.
IC:SKEL
|
Iceland | Ikr19.46 Billion |
|
P.C.B Tec
TA:PCBT
|
Israel | ILA72.52 Million |
|
EMS Limited
NSE:EMSLIMITED
|
India | Rs2.72 Billion |
|
Nanning Baling Technology
SHE:002592
|
China | CN¥320.60 Million |
|
Falcon Oil & Gas Ltd.
V:FO
|
Canada | CA$21.44 Million |
|
JNK India Ltd
NSE:JNKINDIA
|
India | Rs4.91 Billion |
|
Iljin HySolus Co Ltd
KO:271940
|
Korea | ₩35.46 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Guangdong Jiaying Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Guangdong Jiaying Pharmaceutical Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Jiaying Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual total liabilities of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥131.30 Million ≈ $19.21 Million |
+62.91% |
| 2024-12-31 | CN¥80.60 Million ≈ $11.79 Million |
-4.70% |
| 2023-12-31 | CN¥84.58 Million ≈ $12.38 Million |
-28.46% |
| 2022-12-31 | CN¥118.23 Million ≈ $17.30 Million |
-3.76% |
| 2021-12-31 | CN¥122.85 Million ≈ $17.98 Million |
-2.06% |
| 2020-12-31 | CN¥125.43 Million ≈ $18.35 Million |
-34.93% |
| 2019-12-31 | CN¥192.77 Million ≈ $28.21 Million |
+84.99% |
| 2018-12-31 | CN¥104.21 Million ≈ $15.25 Million |
-17.82% |
| 2017-12-31 | CN¥126.80 Million ≈ $18.55 Million |
+10.86% |
| 2016-12-31 | CN¥114.38 Million ≈ $16.74 Million |
-3.31% |
| 2015-12-31 | CN¥118.30 Million ≈ $17.31 Million |
-31.20% |
| 2014-12-31 | CN¥171.94 Million ≈ $25.16 Million |
+57.24% |
| 2013-12-31 | CN¥109.35 Million ≈ $16.00 Million |
+202.31% |
| 2012-12-31 | CN¥36.17 Million ≈ $5.29 Million |
+0.36% |
| 2011-12-31 | CN¥36.04 Million ≈ $5.27 Million |
-15.00% |
| 2010-12-31 | CN¥42.40 Million ≈ $6.20 Million |
+256.15% |
| 2009-12-31 | CN¥11.91 Million ≈ $1.74 Million |
+33.85% |
| 2008-12-31 | CN¥8.89 Million ≈ $1.30 Million |
-72.93% |
| 2007-12-31 | CN¥32.85 Million ≈ $4.81 Million |
-12.21% |
| 2006-12-31 | CN¥37.42 Million ≈ $5.48 Million |
+39.44% |
| 2005-12-31 | CN¥26.84 Million ≈ $3.93 Million |
+16.96% |
| 2004-12-31 | CN¥22.95 Million ≈ $3.36 Million |
-- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablet… Read more